Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3832943 Target Snapshot

Casein kinase 2 · PROTEIN FAMILY · Homo sapiens

355Compounds
123Assays
1Approved Drugs
249.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P67870. Use UniProt P67870 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P67870 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Casein kinase 2 as ChEMBL target CHEMBL3832943, mapped to UniProt P67870. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Casein kinase 2
PROTEIN FAMILY · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL3832943
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P67870
Casein kinase II subunit beta
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Casein kinase 2 is the right protein anchor across sources, using UniProt P67870 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelCasein kinase II subunit beta
UniProt AccessionP67870
Component TypeProtein
Sequence Length215 aa

Casein kinase II subunit beta

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Casein kinase 2, mapped to UniProt P67870. ChEMBL maps the protein component as Casein kinase II subunit beta. Sequence length is 215 aa.

Mapped IDP67870
Review nameCasein kinase 2
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

1
Approved
3
Phase III
10
Phase II
2
Phase I
Assay Mix

Activity Type Distribution

IC50207.0
KI28.0
EC5010.0
KD4.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL5419810 10.08 Ki 0.084 Preclinical
CHEMBL4848224 9.64 IC50 0.23 Preclinical
CHEMBL1230165 9.42 Ki 0.38 Clinical
CHEMBL1682283 9.38 Ki 0.42 Preclinical
CHEMBL4846181 9.38 Ki 0.42 Preclinical
CHEMBL4862003 9.34 IC50 0.46 Preclinical
CHEMBL4872225 9.22 IC50 0.6 Preclinical
CHEMBL4875513 9.21 IC50 0.61 Preclinical
CHEMBL4860630 9.18 IC50 0.66 Preclinical
CHEMBL4848072 9.12 IC50 0.76 Preclinical
Distribution

pChEMBL Value Distribution

40
5.0
37
5.5
51
6.0
24
6.5
9
7.0
13
7.5
13
8.0
7
8.5
10
9.0
1
9.5
pChEMBL
Approved Drugs

Approved Drugs

MITOXANTRONE
CHEMBL58
Approved 1987
Assay Landscape

Assay Landscape

123
Total Assays
187
Tested Compounds
1
Assay Types
Binding — 123 assays, 187 compounds
BAO Format Assays Compounds Avg pChEMBL
protein format 81 162 6.6
cell-based format 39 4 5.6
assay format 3 21 5.8

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine